Analysis of a serum biomarker of exposure to chemical toxicants.
Authors
Kanitz MH
Source
246th National Meeting of the American Chemical Society, September 8-12, 2013, Indianapolis, Indiana. Washington, DC: American Chemical Society, 2013 Sep; 246:78-TOXI
An analytical approach utilizing a sandwich enzyme linked immunosorbent assay (ELISA) was developed to study differences in Clara cell protein (CC16) levels in human serum samples. The National Institute for Occupational Safety and Health is interested in the identification of biomarkers that are related to hazardous occupational chemical exposure. CC16, a secreted protein of human bronchiolar cells, has been observed to decrease in the serum of workers following smoking or silica exposure. This investigation studies differences in CC16 levels in smokers versus non-smokers. Following serum separation from whole blood, standards and serum samples are incubated in microplate wells pre-coated with polyclonal anti-human CC16 antibody. Biotin labeled polyclonal Clara cell antibody is added and incubated with captured CC16. After washing, streptavidin-horseradish peroxidase (HRP) conjugate is added. The remaining conjugate is allowed to react with the substrate solution tetramethylbenzidine (TMB). The absorbance of the resulting yellow product is proportional to the concentration of Clara cell protein. A standard curve is constructed to determine the concentration of CC16 in serum samples. The results are reported as the concentration in ng/ml of CC16. Using this approach the concentration of CC16 in a non-smoker was determined as 12.1 ng/ml. Further analyses of Clara cell protein level in smokers versus non-smokers are compared. The procedure described here can be used to quantitate the level of CC16 biomarker in blood serum samples. This approach is potentially useful for occupational risk assessment for silica exposure, a known chemical hazard in the hydraulic fracturing industry.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.